Outpatient ertapenem therapy in an ESBL-high-prevalence area: an efficacy, safety, and cost study
Arturo Ortiz-Álvarez,1 Mónica A Delgado-Ramírez,1 Montserrat Cuevas-Zúñiga,1 Teresa Hernández-Carrera,1 David Moncada Barrón,2 Daniel Aguilar Zapata,1 Rafael R Valdez Vázquez,1 Juan Pablo Ramírez-Hinoj...
Main Authors: | Ortiz-Álvarez A, Delgado-Ramírez MA, Cuevas-Zuñiga M, Hernández-Carrera T, Moncada Barrón D, Aguilar-Zapata D, Valdez Vázquez RR, Ramírez-Hinojosa JP, Rodríguez-Zulueta AP |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2018-12-01
|
Series: | Infection and Drug Resistance |
Subjects: | |
Online Access: | https://www.dovepress.com/outpatient-ertapenem-therapy-in-an-esbl-high-prevalence-area-an-effica-peer-reviewed-article-IDR |
Similar Items
-
Acute thrombocytosis in a patient treated with ertapenem
by: Edward K. Sarfo, et al.
Published: (2024-01-01) -
In Vitro Effectiveness of Ertapenem Against Enterobacteriaceae Isolates
by: Abdullah KILIÇ, et al.
Published: (2006-03-01) -
Ertapenem Related Neurotoxicity Presented with Visual Halusinations in Chronic Kidney Failure Patient
by: Seçkin Akben, et al.
Published: (2022-10-01) -
Effectiveness of ertapenem for treatment of infections in children: An evidence mapping and meta-analysis
by: Ruiqiu Zhao, et al.
Published: (2022-10-01) -
A Case of Infective Endocarditis Due to Abiotrophia defectiva, and Treatment with Ertapenem
by: Yücel DUMAN, et al.
Published: (2021-12-01)